Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sara Shahriyar, Somayeh Taymouri, Sedigheh Saberi, Parvin Asadi & Majid Tabbakhian. (2021) Preparation and characterization of itraconazole loaded nanomicelles based on dextran–behenic acid for cutaneous leishmaniasis treatment. Drug Development and Industrial Pharmacy 47:3, pages 416-428.
Read now
Read now
Shalini Asthana, Pramod K Gupta, Mohini Chaurasia, Anuradha Dube & Manish K Chourasia. (2013) Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos. Expert Opinion on Drug Delivery 10:12, pages 1633-1651.
Read now
Read now
Swati Gupta, Ajay Pal & Suresh P Vyas. (2010) Drug delivery strategies for therapy of visceral leishmaniasis. Expert Opinion on Drug Delivery 7:3, pages 371-402.
Read now
Read now
Eder L Romero & Maria Jose Morilla. (2008) Drug delivery systems against leishmaniasis? Still an open question. Expert Opinion on Drug Delivery 5:7, pages 805-823.
Read now
Read now
M. Paul, R. Durand, Y. Boulard, T. Fusaï, C. Fernandez, D. Rivollet, M. Deniau & A. Astier. (1998) Physicochemical Characteristics of Pentamidine-Loaded Polymethacrylate Nanoparticles: Implication in the Intracellular Drug Release in Leishmania Major Infected Mice. Journal of Drug Targeting 5:6, pages 481-490.
Read now
Read now
Articles from other publishers (52)
Ilaria Andreana, Valeria Bincoletto, Paola Milla, Franco Dosio, Barbara Stella & Silvia Arpicco. (2022) Nanotechnological approaches for pentamidine delivery. Drug Delivery and Translational Research 12:8, pages 1911-1927.
Crossref
Crossref
Philippe M. Loiseau, Kaluvu Balaraman, Gillian Barratt, Sébastien Pomel, Rémy Durand, Frédéric Frézard & Bruno Figadère. (2022) The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates. Molecules 27:7, pages 2313.
Crossref
Crossref
Ernest Man, Helen P. Price & Clare Hoskins. (2022) Current and future strategies against cutaneous parasites. Pharmaceutical Research 39:4, pages 631-651.
Crossref
Crossref
Mahima Gupta, Atul Pathak, Yashwant V. Pathak & Swati Gupta. 2022. Macrophage Targeted Delivery Systems. Macrophage Targeted Delivery Systems
3
29
.
Pragya Prasanna, Prakash Kumar, Saurabh Kumar, Vinod Kumar Rajana, Vishnu Kant, Surendra Rajit Prasad, Utpal Mohan, V. Ravichandiran & Debabrata Mandal. (2021) Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis – A review. Biomedicine & Pharmacotherapy 141, pages 111920.
Crossref
Crossref
Nikhilesh Joardar, Niladri Mukherjee & Santi P. Sinha Babu. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases
329
356
.
Amir Nafari, Koroush Cheraghipour, Maryam Sepahvand, Ghazal Shahrokhi, Esraa Gabal & Hossein Mahmoudvand. (2020) Nanoparticles: New agents toward treatment of leishmaniasis. Parasite Epidemiology and Control 10, pages e00156.
Crossref
Crossref
Mohammad A. Nilforoushzadeh, Maryam Heidari-Kharaji, Mehrak Zare, Elham Torkamaniha & Sima Rafati. (2020) Novel Strategies and Pharmaceutical Agents for the Treatment of Leishmaniasis: A Review. Anti-Infective Agents 18:2, pages 89-100.
Crossref
Crossref
Shweta Raj, Santanu Sasidharan, S. N. Balaji, Vikash Kumar Dubey & Prakash Saudagar. (2020) Review on natural products as an alternative to contemporary anti-leishmanial therapeutics. Journal of Proteins and Proteomics 11:2, pages 135-158.
Crossref
Crossref
Juliana Souza Ribeiro Costa, Marília Medeiros, Edite Harumi Yamashiro-Kanashiro, Mussya Cisotto Rocha, Paulo Cesar Cotrim, Marco Antonio Stephano, Marcelo Lancellotti, Guilherme Diniz Tavares & Laura Oliveira-Nascimento. (2019) Biodegradable nanocarriers coated with polymyxin B: Evaluation of leishmanicidal and antibacterial potential. PLOS Neglected Tropical Diseases 13:5, pages e0007388.
Crossref
Crossref
Ana Beatriz C. Santos-Valle, Gabriela R.R. Souza, Camila Q. Paes, Takuya Miyazaki, Adny Henrique Silva, Maria J. Altube, Maria J. Morilla, Eder L. Romero, Tânia B. Creczynski-Pasa, Horacio Cabral & Frederico Pittella. (2019) Nanomedicine strategies for addressing major needs in neglected tropical diseases. Annual Reviews in Control 48, pages 423-441.
Crossref
Crossref
Vandana Soni, Silki Chandel, Vikas Pandey, Saket Asati, Priyanka Jain, Aviral Jain & Rakesh K. Tekade. 2019. Biomaterials and Bionanotechnology. Biomaterials and Bionanotechnology
263
300
.
Tianyu Jia, Jingan Rao, Lifang Zou, Shanhong Zhao, Zhihua Yi, Bing Wu, Lin Li, Huilong Yuan, Liran Shi, Chunping Zhang, Yun Gao, Shuangmei Liu, Hong Xu, Hui Liu, Shangdong Liang & Guilin Li. (2018) Nanoparticle-Encapsulated Curcumin Inhibits Diabetic Neuropathic Pain Involving the P2Y12 Receptor in the Dorsal Root Ganglia. Frontiers in Neuroscience 11.
Crossref
Crossref
Bruno Rodrigues do Prado, Arshad Islam, Frédéric Frézard & Cynthia Demicheli. 2017. Drug Discovery for Leishmaniasis. Drug Discovery for Leishmaniasis
199
223
.
Bilal Zulfiqar, Todd B. Shelper & Vicky M. Avery. (2017) Leishmaniasis drug discovery: recent progress and challenges in assay development. Drug Discovery Today 22:10, pages 1516-1531.
Crossref
Crossref
Maryam Akbari, Ahmad Oryan & Gholamreza Hatam. (2017) Application of nanotechnology in treatment of leishmaniasis: A Review. Acta Tropica 172, pages 86-90.
Crossref
Crossref
Swati Pund & Amita Joshi. 2017. Nano- and Microscale Drug Delivery Systems. Nano- and Microscale Drug Delivery Systems
439
480
.
Saurabh Bhatia & Divakar Goli. 2016. Leishmaniasis. Leishmaniasis
23
106
.
CD Shaw & KC Carter. (2014)
Drug delivery: lessons to be learnt from
Leishmania
studies
. Nanomedicine 9:10, pages 1531-1544.
Crossref
Crossref
Masoom YasinzaiMomin Khan, Akhtar Nadhman & Gul Shahnaz. (2013) Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives. Future Medicinal Chemistry 5:15, pages 1877-1888.
Crossref
Crossref
T.T.H. Pham, P.M. Loiseau & G. Barratt. (2013) Strategies for the design of orally bioavailable antileishmanial treatments. International Journal of Pharmaceutics 454:1, pages 539-552.
Crossref
Crossref
Shegokar Ranjita. (2013) Nanosuspensions: a new approach for organ and cellular targeting in infectious diseases. Journal of Pharmaceutical Investigation 43:1, pages 1-26.
Crossref
Crossref
Philippe M. Loiseau & Gillian Barratt. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
321
350
.
Sílvia Vale-Costa, Nuno Vale, Joana Matos, Ana Tomás, Rui Moreira, Paula Gomes & Maria Salomé Gomes. (2012) Peptidomimetic and Organometallic Derivatives of Primaquine Active against Leishmania infantum. Antimicrobial Agents and Chemotherapy 56:11, pages 5774-5781.
Crossref
Crossref
Saied Soflaei, Abdolhossein Dalimi, Fatemeh Ghaffarifar, Mojtaba Shakibaie, Ahmad Reza Shahverdi & Mohsen Shafiepour. (2012)
In Vitro
Antiparasitic and Apoptotic Effects of Antimony Sulfide Nanoparticles on
Leishmania infantum
. Journal of Parasitology Research 2012, pages 1-7.
Crossref
Crossref
B. Heurtault, F. Schuber & B. Frisch. 2009. Nanoscience. Nanoscience
1097
1119
.
Shyam Sundar & Madhukar Rai. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
1101
1112
.
Kamalinder K. Singh & Sharvani K. Vingkar. (2008) Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. International Journal of Pharmaceutics 347:1-2, pages 136-143.
Crossref
Crossref
Payal Agrawal, Umesh Gupta & N.K. Jain. (2007) Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials 28:22, pages 3349-3359.
Crossref
Crossref
Babu L Tekwani & Larry A Walker. (2006) 8-Aminoquinolines: future role as antiprotozoal drugs. Current Opinion in Infectious Diseases 19:6, pages 623-631.
Crossref
Crossref
Jose Piñero, Rosane M. Temporal, Antonio J. Silva-Gonçalves, I.A. Jiménez, Isabel L. Bazzocchi, Alexis Oliva, Antonio Perera, Leonor L. Leon & Basilio Valladares. (2006) New administration model of trans-chalcone biodegradable polymers for the treatment of experimental leishmaniasis. Acta Tropica 98:1, pages 59-65.
Crossref
Crossref
Fatiha Chellat, Yahye Merhi, Alain Moreau & L’Hocine Yahia. (2005) Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 26:35, pages 7260-7275.
Crossref
Crossref
Chang-Sik Ha & Joseph A. Gardella. (2005) Surface Chemistry of Biodegradable Polymers for Drug Delivery Systems. Chemical Reviews 105:11, pages 4205-4232.
Crossref
Crossref
Annie M. Dierling & Zhengrong Cui. (2005) Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy. International Journal of Pharmaceutics 303:1-2, pages 143-152.
Crossref
Crossref
M. A. Dea-Ayuela, S. Rama-Iniguez, J. A. Sanchez-Brunete, J. J. Torrado, J. M. Alunda & F. Bolas-Fernandez. (2004) Anti-leishmanial activity of a new formulation of amphotericin B. Tropical Medicine and International Health 9:9, pages 981-990.
Crossref
Crossref
Luciana Fumarola, Rosa Spinelli & Olga Brandonisio. (2004) In vitro assays for evaluation of drug activity against Leishmania spp.. Research in Microbiology 155:4, pages 224-230.
Crossref
Crossref
M Brzoska, K Langer, C Coester, S Loitsch, T.O.F Wagner & C.v Mallinckrodt. (2004) Incorporation of biodegradable nanoparticles into human airway epithelium cells—in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochemical and Biophysical Research Communications 318:2, pages 562-570.
Crossref
Crossref
E Fattal, D Labarre & C Vauthier. 2003. Tissue Engineering And Novel Delivery Systems. Tissue Engineering And Novel Delivery Systems.
Christine Vauthier, Catherine Dubernet, Elias Fattal, Huguette Pinto-Alphandary & Patrick Couvreur. (2003) Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Advanced Drug Delivery Reviews 55:4, pages 519-548.
Crossref
Crossref
Paraskevi Kallinteri & Martin C. Garnett. 2007. Nanotechnologies for the Life Sciences. Nanotechnologies for the Life Sciences.
M Simeonova, M Antcheva & K Chorbadjiev. (2003) Study on the effect of polybutyl-2-cyanoacrylate nanoparticles and their metabolites on the phagocytic activity of peritoneal exudate cells of mice. Biomaterials 24:2, pages 313-320.
Crossref
Crossref
Christine Vauthier & Patrick Couvreur. 2005. Biopolymers Online. Biopolymers Online.
Chi Wu, Jie Fu & Yue Zhao. (2000)
Novel Nanoparticles Formed via Self-Assembly of Poly(ethylene glycol-
b
-sebacic anhydride) and Their Degradation in Water
. Macromolecules 33:24, pages 9040-9043.
Crossref
Crossref
E. Cauchetier, M. Paul, D. Rivollet, H. Fessi, A. Astier & M. Deniau. (2000) Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis. International Journal for Parasitology 30:6, pages 777-783.
Crossref
Crossref
Eduardo Caio Torres-Santos, José M. RodriguesJr.Jr., Davyson L. Moreira, Maria Auxiliadora C. Kaplan & Bartira Rossi-Bergmann. (1999)
Improvement of In Vitro and In Vivo Antileishmanial Activities of 2′,6′-Dihydroxy-4′-Methoxychalcone by Entrapment in Poly(
d,l
-Lactide) Nanoparticles
. Antimicrobial Agents and Chemotherapy 43:7, pages 1776-1778.
Crossref
Crossref
Japp J. Van Hellemond, Bert Simons, Frank F. Millenaar & Aloysius G.M. Tielens. (2007)
A Gene Encoding the Plant‐Like Alternative Oxidase is Present in
Phytomonas
but Absent in
Leishmania
spp.
. Journal of Eukaryotic Microbiology 45:4, pages 426-430.
Crossref
Crossref
Muriel Paul, Abdelkader Laatiris, Hatem Fessi, Barbara Dufeu, R�my Durand, Mich�le Deniau & Alain Astier. (1998) Pentamidine-loaded poly(D,L-lactide) nanoparticles: Adsorption and drug release. Drug Development Research 43:2, pages 98-104.
Crossref
Crossref
M Paul, H Fessi, A Laatiris, Y Boulard, R Durand, M Deniau & A Astier. (1997) Pentamidine-loaded poly(d,l-lactide) nanoparticles: physicochemical properties and stability work. International Journal of Pharmaceutics 159:2, pages 223-232.
Crossref
Crossref
M.S. Espuelas, P. Legrand, J.M. Irache, C. Gamazo, A.M. Orecchioni, J.-Ph. Devissaguet & P. Ygartua. (1997) Poly(ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity. International Journal of Pharmaceutics 158:1, pages 19-27.
Crossref
Crossref
Jaap J Van Hellemond & Aloysius G.M Tielens. (1997) Inhibition of the respiratory chain results in a reversible metabolic arrest in Leishmania promastigotes. Molecular and Biochemical Parasitology 85:1, pages 135-138.
Crossref
Crossref
Vinod Labhasetwar, Cunxian Song & Robert J. Levy. (1997) Nanoparticle drug delivery system for restenosis. Advanced Drug Delivery Reviews 24:1, pages 63-85.
Crossref
Crossref
A. Bender, V. Sch?fer, A.M. Steffan, C. Royer, J. Kreuter, H. R?bsamen-Waigmann & H. von Briesen. (1994) Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles. Research in Virology 145, pages 215-220.
Crossref
Crossref